Table 3.
FGF23/FePi Category | Participants | Events | Model 1 HR (95% CI) | Model 2 HR (95% CI) |
---|---|---|---|---|
All-cause mortalitya | ||||
Low FGF23/low FePi | 240 | 68 | 1.00 (reference) | 1.00 (reference) |
Low FGF23/high FePi | 197 | 62 | 0.97 (0.68, 1.37) | 0.99 (0.70, 1.42) |
High FGF23/high FePi | 239 | 119 | 1.96 (1.45, 2.66) | 1.49 (1.07, 2.07) |
High FGF23/low FePi | 196 | 88 | 2.21 (1.60, 3.06) | 1.98 (1.42, 2.77) |
CVD events (MI, stroke, and CVD death)b | ||||
Low FGF23/low FePi | 240 | 39 | 1.00 (reference) | 1.00 (reference) |
Low FGF23/high FePi | 197 | 39 | 1.09 (0.69, 1.70) | 1.04 (0.66, 1.63) |
High FGF23/high FePi | 239 | 66 | 1.69 (1.13, 2.53) | 1.21 (0.78, 1.86) |
High FGF23/low FePi | 196 | 55 | 2.22 (1.46, 3.36) | 1.92 (1.25, 2.94) |
Model 1, age, sex, estrogen use (women), and race adjusted; model 2, model 1 plus diabetes, systolic BP, BMI, total cholesterol, HDL cholesterol, smoking, CRP, eGFR, ACR, and PTH.
P interaction FGF23 × FePi<0.001.
P interaction FGF23 × FePi=0.05.